Table 3: Treatment modality compared
after the subtypes squamous cell carcinoma, adenocarcinoma and adeno-squamous
cancer, (n=253).
|
Histopathology |
Squamous
cell carcinoma |
Adeno-carcinoma |
Adeno-
squam. Ca |
P value |
|
|
No
(%) |
No
(%) |
No
(%) |
|
|
|
150
(%) |
74
(%) |
29(%) |
|
|
Operative
treatment |
|
|
|
|
|
Total
(n = 207) |
|
|
|
|
|
Radical |
|
|
|
|
|
hysterectomy |
73
(48.7 %) |
54
(36.0 %) |
23
(15.3 %) |
|
|
(n
= 150) |
|
|
|
|
|
Total |
|
|
|
|
|
hysterectomy |
25
(83 % ) |
5
(17 %) |
0 |
|
|
(n
= 30) |
|
|
|
|
|
Trachelectomy |
21
(77.8 %) |
5
(18.5 %) |
1
(0.37%) |
|
|
(n
= 27) |
|
|
|
|
|
|
119 |
64 |
24 |
|
|
(chi-2 test) |
|
|
|
0.003 |
|
Post-operative
oncological treatment (n = 29) |
|
|
|
|
|
Radio-chemotherapy |
14
(52 %) |
5
(18 %) |
8
(30 %) |
|
|
(n=27) |
|
|
|
|
|
Radiotherapy
(only) |
1
(50 %) |
|
1
(50 %) |
|
|
(n=2) |
|
|
|
|
|
(chi-2 test) |
|
|
|
0.775 |
|
Primary
oncological treatment (n = 46) |
|
|
|
|
|
Radio-chemotherapy |
23
(62 %) |
10
(30 %) |
4
(8 %) |
|
|
Primary
radiotherapy |
8
(89 %) |
0 |
1
(11%) |
|
|
(chi-2 test) |
|
|
|
0.170 |